Biologics Aesculap Biologics, LLC Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of NOVOCART® 3D in Patients with Articular Cartilage Defects of the Knee byJosh SandbergFebruary 28, 2019
Financial RTI Surgical® Announces Fourth Quarter and Full Year 2018 Results byJosh SandbergFebruary 28, 2019
Biologics Spine Medtronic Announces Approval and Launch of Japan’s First DBM Bone Grafting Product for Spine and Orthopedic Procedures byChris StewartFebruary 28, 2019
Financial SeaSpine Announces Fourth Quarter and Full-Year 2018 Results and Reaffirms 2019 Revenue Guidance byJosh SandbergFebruary 27, 2019
Spine Top Stories Atlas Spine Inc. completes alpha phase and announces the full launch of its first-to-market HiJak™ AC Expandable Cervical IBFD. byJosh SandbergFebruary 27, 2019
Financial Hospitals Survey: Physicians net $2.4M in revenue for hospitals each year byChris StewartFebruary 27, 2019
Biologics Bone Solutions Inc. Successfully surpasses 500 implanted cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergFebruary 26, 2019
Extremities IlluminOss Medical Launches the IlluminOss® Bone Stabilization System for Use in the Treatment of Traumatic and Fragility Fractures in the U.S. byJosh SandbergFebruary 26, 2019
Financial TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2018 byJosh SandbergFebruary 26, 2019
